| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/14/2023 | NOVINT TECHNOLOGIES INC | NVNT | Grant | Series A Convertible Preferred Stock | 592.2k | $0.01 | $6.5k | See footnote | 08/14/2023 |
| 08/14/2023 | NOVINT TECHNOLOGIES INC | NVNT | Grant | Common Warrants | 42.4M | $0.03 | $1.4M | See footnote | 08/14/2023 |
| 11/18/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock | 40.4k | $1.10 | $44.4k | | 10/21/2022 |
| 11/18/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock | 40.4k | $1.10 | $44.4k | | 10/21/2022 |
| 11/17/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock | 171.8k | $1.08 | $185.5k | | 10/21/2022 |
| 11/17/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock | 171.8k | $1.08 | $185.5k | | 10/21/2022 |
| 11/16/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock | 287.8k | $0.99 | $284.9k | | 10/21/2022 |
| 11/16/2022 | NRX Pharmaceuticals, Inc. | NRXP | Purchase | Common Stock | 287.8k | $0.99 | $284.9k | | 10/21/2022 |
| 10/21/2022 | NRX Pharmaceuticals, Inc. | NRXP | Grant | Employee Stock Option | 162.7k | $0.75 | $122k | | 10/21/2022 |
| 05/24/2021 | NRX Pharmaceuticals, Inc. | NRXP | Grant | Common Stock | 208.4k | $0.00 | $0 | See footnote | 05/24/2021 |
| 05/24/2021 | NRX Pharmaceuticals, Inc. | NRXP | Grant | Common Stock Warrant (Right to buy) | 218.4k | $1.53 | $334.2k | See footnote | 05/24/2021 |
| 05/24/2021 | NRX Pharmaceuticals, Inc. | NRXP | Grant | Common Stock | 1.4M | $0.00 | $0 | See footnote | 05/24/2021 |